Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Aga Medical Corp.

US

Last updated May 23, 2026

What Aga Medical Corp. makes

Aga Medical Corp. manufactures cardiac defect occluders, including devices for closing atrial and ventricular septal defects, along with metallic embolization plugs for non-neurovascular embolization procedures. Their portfolio also includes single-use guidewires for cardiac and peripheral vascular applications, as well as atrial septal defect sizing plates for pre-procedural assessment.

The company’s devices are regulated under FDA classifications, including Class I, Class II, and Class III, with submissions recorded in the FDA’s 510(k) and UDI registries. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (126)

Page 3 of 3
DeviceModel / ReferenceRegistriesClassStatus
Amplatzer™ 9-ASD-012
FDA UDI
Class IIIActive
Amplatzer™ Post Infarct Muscular VSD Occluder
FDA UDI
Class IIIActive
Amplatzer™ 9-AVP2-018
FDA UDI
Class IIActive
Amplatzer™ 9-ASD-004
FDA UDI
Class IIIActive
Amplatzer™ Septal Occluder
FDA UDI
Class IIIActive
Amplatzer™ Septal Occluder
FDA UDI
Class IIIActive
Amplatzer™ 9-AVP2-003
FDA UDI
Class IIActive
Amplatzer™ Septal Occluder
FDA UDI
Class IIIActive
Amplatzer™ 9-EITV12F45/80
FDA UDI
Class IIActive
Amplatzer™ Septal Occluder
FDA UDI
Class IIIActive
Amplatzer Torqvue Exchange System K080994
FDA 510(k)
Class IIActive
Amplatzer Vascular Plug Ii Models: Avp2-004, Avp2-006, Avp2-008, Avp2-010, Avp2-012, Avp2-014, Avp2-016 K071125
FDA 510(k)
Class IIActive
Amplatzer Vascular Plug K031810
FDA 510(k)
Class IIActive
Amplatzer Torqvue Delivery System K072313
FDA 510(k)
Class IIActive
Amplatzer Torqvue 45x45 Delivery Sheath Amplatzer Torqvue La1 Delivery Sheath Amplatzer Torqvue La2 Selivery Sheath K120120
FDA 510(k)
Class IIActive
Amplatzer Torqvue Low Profile Delivery System K080757
FDA 510(k)
Class IIActive
Amplatzer Sizing Balloon K993248
FDA 510(k)
Class IIActive
Amplatzer Vascular Plug 4 K113658
FDA 510(k)
Class IIActive
Amplatzer Reliant Catheter Delivery System K070238
FDA 510(k)
Class IIActive
Amplatzer Noodlewire Guidewire K053187
FDA 510(k)
Class IIActive
Amplatzer Sizing Balloon Ii K053440
FDA 510(k)
Class IIActive
Amplatzer Torqvue 45degreex45degree Delivery Sheath, Models 9-Tv45x45-09f-100, 9-Tv45x45-10f-100 K083214
FDA 510(k)
Class IIActive
Amplatzer Torqvue 3 Delivery Sheath, Model 9-Tv3-08f104, 9-Tv3-08f54 K091793
FDA 510(k)
Class IIActive
Amplatzer Torqvue Fx K121611
FDA 510(k)
Class IIActive
Amplatzer Vascular Plug Ii, Models Avp2-003, Avp2-018, Avp2-020, Avp2-022 K071699
FDA 510(k)
Class IIActive
Amplatzer Torq Vue 2 Delivery Sheath Model 9-Tv2-05f120, Model 9-Tv2-06f120, Modeltv-2-07f120 K093476
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (32)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Aga Medical Corp. has 32 recall records initiated between November 23, 2004, and December 17, 2010, all of which are recorded as terminated. The recalls involved issues such as outer pouch seal integrity failures in specific delivery systems and sizing balloons, mislabeling of AMPLATZER PFO Occluders and sizing balloons with incorrect device sizes, and tubing residue from manufacturing deviations. Additional recalls addressed potential sterile barrier breaches in delivery system packaging, improper sterilization validation for AMPLATZER Vascular Plugs, and PTFE plastic lining fragments from occluder screws.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Dec 17, 2010Z-1595-2011—terminated

AGA Medical is initiating a voluntary recall of a specific lot of mislabeled AMPLATZER Sizing Balloon II. AGA Medical received 2 reports from customers who received sizing balloons that were labeled as 34 mm; however, the package contained 24 mm devices. The proper sizing (24 mm) was printed on the device hub visible through the product package.

Dec 18, 2009Z-1101-2010—terminated

In this lot of TorqVue Delivery Systems (PN: 9-ITV10F45/80, LN: 0906151781), the dilator cannot be fully secured to the sheath as directed by the instructions for use.

Apr 25, 2008Z-2193-2008—terminated

AGA Medical Corporation has identified an issue with outer pouch seal integrity within one production lot of 10 French 45/80 delivery systems and one lot of 24 mm Sizing Balloon. We have not observed incomplete seals with the inner pouch. An intact inner pouch seal will maintain device sterility. AGA is asking that customers inspect the specific lot of devices to confirm the integrity of the ou

Apr 25, 2008Z-2192-2008—terminated

AGA Medical Corporation has identified an issue with outer pouch seal integrity within one production lot of 10 French 45/80 delivery systems and one lot of 24 mm Sizing Balloon. We have not observed incomplete seals with the inner pouch. An intact inner pouch seal will maintain device sterility. AGA is asking that customers inspect the specific lot of devices to confirm the integrity of the ou

Oct 2, 2006Z-0255-2007—terminated

AGA Medical has found that microscopic tears can occur in the delivery system sterile packaging under accelerated stress testing with routine shipping configurations. These microscopic tears are a potential breach of the sterile barrier. AGA has no confirmed complaints or adverse events related to this failure mode.

Oct 2, 2006Z-0257-2007—terminated

AGA Medical has found that microscopic tears can occur in the delivery system sterile packaging under accelerated stress testing with routine shipping configurations. These microscopic tears are a potential breach of the sterile barrier. AGA has no confirmed complaints or adverse events related to this failure mode.

Oct 2, 2006Z-0256-2007—terminated

AGA Medical has found that microscopic tears can occur in the delivery system sterile packaging under accelerated stress testing with routine shipping configurations. These microscopic tears are a potential breach of the sterile barrier. AGA has no confirmed complaints or adverse events related to this failure mode.

Jun 1, 2006Z-0052-2007—terminated

AMPLATZER PFO Occluders were mislabeled with incorrect device sizes. The lot M06B01-58 contains 18mm PFO Occluders but is labeled as containing 25mm devices. Lot M06B01-52 contains 25mm PFO Occluders but is labeled as containing 18mm devices. This device was not distributed within the United States and does not affect U.S. consignees.

Jun 1, 2006Z-0053-2007—terminated

AMPLATZER PFO Occluders were mislabeled with incorrect device sizes. The lot M06B01-58 contains 18mm PFO Occluders but is labeled as containing 25mm devices. Lot M06B01-52 contains 25mm PFO Occluders but is labeled as containing 18mm devices. The affected product was not distributed within the United States and does not affect U.S. consignees.

Sep 6, 2005Z-0464-06—terminated

The pointed end of a screw securing the occluder to the delivery cable could scrape off microscopic fragments of the polytetrafluorethylene (PTFE) plastic lining of the sheath. Those shavings could potentially migrate into a patient's bloodstream.

Sep 6, 2005Z-0461-06—terminated

The pointed end of a screw securing the occluder to the delivery cable could scrape off microscopic fragments of the polytetrafluorethylene (PTFE) plastic lining of the sheath. Those shavings could potentially migrate into a patient's bloodstream.

Sep 6, 2005Z-0462-06—terminated

The pointed end of a screw securing the occluder to the delivery cable could scrape off microscopic fragments of the polytetrafluorethylene (PTFE) plastic lining of the sheath. Those shavings could potentially migrate into a patient's bloodstream.

Sep 6, 2005Z-0463-06—terminated

The pointed end of a screw securing the occluder to the delivery cable could scrape off microscopic fragments of the polytetrafluorethylene (PTFE) plastic lining of the sheath. Those shavings could potentially migrate into a patient's bloodstream.

Sep 6, 2005Z-0465-06—terminated

The pointed end of a screw securing the occluder to the delivery cable could scrape off microscopic fragments of the polytetrafluorethylene (PTFE) plastic lining of the sheath. Those shavings could potentially migrate into a patient's bloodstream.

Sep 1, 2005Z-0127-06—terminated

Five lots of AMPLATZER Vascular Plugs were sterilized in a load that was not validated for the AMPLATZER Vascular Plug. However, only three of those five lots were distributed.

Nov 23, 2004Z-0366-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0360-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0350-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0365-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0358-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0362-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0359-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0357-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0355-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0364-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0351-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0356-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0361-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0352-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0353-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0363-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.

Nov 23, 2004Z-0354-05—terminated

Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.